Vancouver, Canada

Duncan Browman

This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Zymeworks Bc Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Duncan Browman. Retrieved from https://idiyas.com/inventor/duncan-browman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 18.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Duncan Browman: Innovator in Antibody-Drug Conjugates

Introduction

Duncan Browman is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of antibody-drug conjugates (ADCs) for cancer treatment. His innovative work has the potential to improve therapeutic outcomes for patients suffering from various forms of cancer.

Latest Patents

Duncan Browman holds a patent for "Antibody-drug conjugates targeting folate receptor alpha and methods of use." This patent describes ADCs that comprise an antibody construct specifically designed to bind to the human folate receptor alpha (FRα). The conjugates are linked to a camptothecin analogue, making them useful as therapeutics, especially in cancer treatment. He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Browman is currently associated with Zymeworks BC Inc., a company that focuses on developing innovative therapeutic solutions. His work at Zymeworks has allowed him to contribute to cutting-edge research and development in the field of antibody-drug conjugates.

Collaborations

Duncan has collaborated with several professionals in his field, including James R. Rich and Stuart Daniel Barnscher. These collaborations have likely enhanced the quality and impact of his research, leading to advancements in therapeutic applications.

Conclusion

Duncan Browman is a prominent figure in the biotechnology sector, particularly known for his work on antibody-drug conjugates. His innovative patent and contributions to Zymeworks BC Inc. highlight his commitment to improving cancer treatment through advanced therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…